Lymphocyte-activation gene 3 (LAG-3) as a promising immune checkpoint in cancer immunotherapy: From biology to the clinic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lymphocyte-activation gene 3 (LAG-3) as a promising immune checkpoint in cancer immunotherapy: From biology to the clinic

Published:2024-02 Issue: Volume:254 Page:155124
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Alqurashi Yaser E.

Funder

Majmaah University

Publisher

Elsevier BV

Reference106 articles.

1. Discovery of first-in-class small molecule inhibitors of lymphocyte activation gene 3 (LAG-3);Abdel-Rahman;ACS Med. Chem. Lett.,2023

2. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation;Anderson;Immunity,2016

3. Molecular pathways and mechanisms of LAG3 in cancer therapy;Andrews;Clin. Cancer Res.,2022

4. LAG 3 (CD 223) as a cancer immunotherapy target;Andrews;Immunol. Rev.,2017

5. Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson’s disease: molecular mechanisms connecting neuroinflammation to α-synuclein spreading pathology;Angelopoulou;Biology,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses;International Journal of Molecular Sciences;2024-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP